From complex blood cancers to common anemia, Dr. Vairamoorthy provides expert diagnosis and treatment for the complete range of hematological conditions. His practice combines over 180 successful bone marrow transplants, pioneering CAR T-cell therapy, and published research in prestigious medical journals to offer patients access to the most advanced and effective treatments available.
Dr. Vairamoorthy is at the forefront of cellular immunotherapy, specializing in CAR T (Chimeric Antigen Receptor T-cell) therapy for patients with relapsed and refractory blood cancers. This cutting-edge treatment harnesses the power of the patient’s own immune system to fight cancer.
His expertise includes managing complex CAR T-cell therapy protocols, active participation in clinical trials, and published research in the New England Journal of Medicine on enhanced CAR T-cell therapy for relapsed lymphoma. Dr. Vairamoorthy also specializes in designing Phase I and II clinical trial protocols for investigational cellular therapies.
With experience in over 180 bone marrow transplants, Dr. Vairamoorthy provides comprehensive stem cell transplantation services for both malignant and benign haematological conditions. His expertise encompasses the entire transplant journey—from pre-transplant evaluation and conditioning through post-transplant care and complication management.
Dr. Vairamoorthy has published research on salvage therapies for relapsed severe aplastic anemia, demonstrating his commitment to advancing transplant outcomes even in complex cases.
Dr. Vairamoorthy specializes in the diagnosis and comprehensive management of all blood cancers, combining the latest targeted therapies with evidence-based treatment protocols. His approach integrates advanced molecular profiling through next-generation sequencing to personalize treatment strategies and optimize outcomes.
His research contributions include studies on novel combination therapies such as Azacitidine and Venetoclax for acute myeloid leukemia, molecular risk stratification, and management of AL Amyloidosis. Patients benefit from access to cutting-edge clinical trials and investigational treatments.
Dr. Vairamoorthy provides comprehensive care for all non-cancerous blood disorders, from common anemias to rare immune-mediated conditions. His specialized expertise includes advanced diagnostic capabilities using flow cytometry, coagulation studies, and bone marrow examination.
Notable research contributions include groundbreaking work on rapid diagnosis of hemophagocytic lymphohistiocytosis (HLH) using flow cytometry and management strategies for rare conditions like Schnitzler syndrome.